The next era of healthcare is personal
5/21/202626 min
For more than a century, medicine has largely followed a one-size-fits-all model—but that paradigm is beginning to break. On this episode of The McKinsey Podcast, Stéphane Bancel, CEO of Moderna, joins Eric Kutcher, McKinsey’s North America chair, to explore how mRNA technology is transforming healthcare. From the rapid development of COVID-19 vaccines to new approaches to rare genetic diseases and individualized cancer treatments, Bancel explains how treating biology as information could reshape how drugs are discovered, manufactured, and delivered.
This is the second episode in a recurring series in which Eric talks with top CEOs about the practice of leadership.
The McKinsey Podcast is cohosted by Lucia Rahilly and Roberta Fusaro.
To watch the full-length version of this interview, go to The McKinsey Podcast’s YouTube channel.
See www.mckinsey.com/privacy-policy for privacy information
Clips
Transcript preview
First 90 secondsLucia Rahilly· Host0:00
[upbeat music] Hey, Roberta.
Roberta Fusaro· Host0:03
Hey, Lucia. How's it going?
Lucia Rahilly· Host0:05
It's going well, and welcome to our audience. On today's episode of the McKinsey Podcast, we've got Eric Kutcher, our North America managing partner, and Stéphane Bancel, the CEO of Moderna. Stéphane actually led Moderna through the development and release of the COVID-19 mRNA vaccine.
Roberta Fusaro· Host0:27
Very cool. You know, we were just talking about vaccines the other night. My sons were asking all these questions about the hantavirus. We've been reading- Ah ... so much about- Right ... the status and, and what's going on there. From what I've read, there are some vaccines that are being developed, but none have been approved for the hantavirus.
Lucia Rahilly· Host0:49
Right. It's hard not to flash back when reading about hantavirus to the bad old days of the COVID pandemic, and that wait for the development of vaccines, which at the time seemed so long but was actually incredibly quick in retrospect. One was, of course, Moderna.
Roberta Fusaro· Host1:11
So let's hear from Eric and Stéphane about how AI and Moderna's technology are transforming healthcare.
Eric Kutcher1:18
[upbeat music] So welcome to the McKinsey Podcast. I am joined today